Skip to main content

Table 3 PV seroprevalence of IPV-immunized children compared to OPV-immunized children in a previous study [10]

From: A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people

 

No. of samples (%)

All positive

PV1-negative

PV2-negative

PV3-negative

All negative

IPV-immunized children (6–10 years, n = 236)

195 (82.6%)

16 (2.6%)

8 (1.0%)

29 (7.5%)

3 (1.3%)

OPV-immunized children [10] (6–11 years, n = 500)

411 (82.2%)

13 (6.8%)

5 (3.4%)

38 (12.3%)

0 (0%)

P value*

>0.05

<0.01

<0.05

<0.05

<0.05

  1. *P < 0.05 indicates significant differences of seroprevalence among the compared groups.
  2. IPV, inactivated polio vaccine; OPV, oral poliovirus vaccine; PV, poliovirus.